BDH Industries Submits SEBI Compliance Certificate for Quarter Ended March 31, 2026

1 min read     Updated on 08 Apr 2026, 10:40 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

BDH Industries Limited filed its mandatory SEBI compliance certificate for the quarter ended March 31, 2026, confirming proper dematerialisation procedures. The certificate was submitted to BSE Limited on April 8, 2026, with confirmation from registrar MUFG Intime India Private Limited that all securities processing was completed within prescribed timelines and regulatory requirements.

powered bylight_fuzz_icon
37213841

*this image is generated using AI for illustrative purposes only.

BDH Industries Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory obligations under SEBI (Depositories and Participants) Regulations 2018. The certificate covers the quarter ended March 31, 2026, and was filed on April 8, 2026.

Regulatory Compliance Filing

The compliance certificate was issued pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018. Company Secretary Nikita Phatak signed and submitted the document to BSE Limited, with copies forwarded to National Securities Depository Limited and Central Depository Services (India) Limited.

Filing Details: Information
Quarter Period: March 31, 2026
Filing Date: April 8, 2026
Reference Number: BDH/SEC/007/2026-27
Signatory: Nikita Phatak, Company Secretary

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, serves as the company's registrar and share transfer agent. The registrar provided confirmation on April 7, 2026, certifying compliance with dematerialisation procedures during the quarter.

The registrar confirmed that all securities received from depository participants for dematerialisation were properly processed. Assistant Vice President Deepak Tambe signed the confirmation certificate on behalf of MUFG Intime India Private Limited.

Compliance Verification

The certificate confirms several key compliance aspects:

  • Securities received for dematerialisation were confirmed or rejected to depositories within prescribed timelines
  • All security certificates were properly mutilated and cancelled after verification
  • Depository names were substituted in the register of members as registered owners
  • Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed

Company Credentials

BDH Industries Limited maintains several quality certifications and accreditations. The company holds Star Export House status, WHO-GMP Accreditation, and ISO 9001:2015 certification, demonstrating its commitment to quality standards across operations.

The quarterly filing represents routine regulatory compliance, ensuring transparency in share transfer and depository operations. The company's adherence to SEBI regulations maintains investor confidence and regulatory standing in the Indian capital markets.

Historical Stock Returns for BDH Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.24%-2.38%-0.29%-13.72%+35.25%+280.36%

Will BDH Industries' Star Export House status and WHO-GMP accreditation help expand its international market presence in the upcoming quarters?

How might the transition from Link Intime to MUFG Intime as registrar impact BDH Industries' future share transfer operations and costs?

What strategic initiatives is BDH Industries planning that could affect its dematerialization volumes in the next fiscal year?

BDH Industries Publishes Q3FY26 Results with 81% Revenue Growth Under SEBI Compliance

2 min read     Updated on 13 Feb 2026, 03:32 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

BDH Industries delivered exceptional Q3FY26 performance with revenue surging 81.18% year-over-year to ₹2933.89 lakhs, driven primarily by pharmaceutical segment growth. Net profit increased 24.21% to ₹348.90 lakhs while maintaining healthy margins. The company has fulfilled all regulatory obligations by publishing results in prescribed newspaper formats under SEBI compliance requirements.

powered bylight_fuzz_icon
32361000

*this image is generated using AI for illustrative purposes only.

BDH Industries Limited has announced strong financial results for the third quarter ended 31st December 2025, showcasing significant growth across key performance metrics. The Mumbai-based company, operating in pharmaceuticals and renewable energy segments, demonstrated robust operational performance with substantial revenue expansion and improved profitability.

Quarterly Financial Performance

The company delivered impressive quarterly results with revenue from operations reaching ₹2933.89 lakhs, representing a remarkable 81.18% year-over-year increase from ₹1619.63 lakhs in Q3FY25. Sequential growth was equally strong, with revenue rising 54.76% from ₹1895.92 lakhs in Q2FY26.

Metric: Q3FY26 Q3FY25 YoY Change Q2FY26 QoQ Change
Revenue from Operations: ₹2933.89 lakhs ₹1619.63 lakhs +81.18% ₹1895.92 lakhs +54.76%
Net Profit After Tax: ₹348.90 lakhs ₹280.90 lakhs +24.21% ₹261.91 lakhs +33.21%
Earnings Per Share: ₹6.06 ₹4.88 +24.18% ₹4.55 +33.19%

Net profit after tax grew to ₹348.90 lakhs, marking a 24.21% increase from ₹280.90 lakhs in the corresponding quarter of the previous year. The profit margin remained healthy despite the significant revenue expansion, indicating effective cost management and operational efficiency.

Nine-Month Performance Analysis

For the nine-month period ended 31st December 2025, BDH Industries maintained its growth trajectory with revenue from operations of ₹6692.23 lakhs, up 37.45% from ₹4868.67 lakhs in the same period last year. Nine-month net profit reached ₹793.47 lakhs compared to ₹678.46 lakhs in the previous year, representing a 16.95% increase.

Parameter: 9M FY26 9M FY25 Growth
Revenue from Operations: ₹6692.23 lakhs ₹4868.67 lakhs +37.45%
Net Profit After Tax: ₹793.47 lakhs ₹678.46 lakhs +16.95%
Earnings Per Share: ₹13.78 ₹11.78 +16.98%

Segment-wise Performance

The pharmaceutical segment continues to be the primary growth driver, contributing ₹2919.74 lakhs to quarterly revenue compared to ₹1604.55 lakhs in Q3FY25. The renewable energy segment generated ₹14.15 lakhs in quarterly revenue, slightly lower than ₹15.08 lakhs in the corresponding quarter last year.

Segment: Q3FY26 Revenue Q3FY25 Revenue 9M FY26 Revenue 9M FY25 Revenue
Pharmaceuticals: ₹2919.74 lakhs ₹1604.55 lakhs ₹6625.24 lakhs ₹4786.18 lakhs
Renewable Energy: ₹14.15 lakhs ₹15.08 lakhs ₹66.99 lakhs ₹82.49 lakhs

Regulatory Compliance and Publication

BDH Industries has fulfilled its regulatory obligations under SEBI Listing Obligations and Disclosure Requirements Regulations 2015. Company Secretary and Compliance Officer Nikita Phatak confirmed that the standalone unaudited financial results for Q3FY26 have been published in newspapers including Free Press Journal in English and Navshakti in Marathi language, ensuring compliance with Regulation 30 and Regulation 47.

Board Approval and Audit Review

The Board of Directors approved these unaudited financial results at their meeting held on 11th February 2026. The results were reviewed by the Audit Committee and received an unmodified review conclusion from the statutory auditors, CLB & Associates, Chartered Accountants. The company maintains full compliance with prescribed disclosure formats and regulatory requirements.

Historical Stock Returns for BDH Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.24%-2.38%-0.29%-13.72%+35.25%+280.36%

More News on BDH Industries

1 Year Returns:+35.25%